Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) and the Progressing Litigation on Behalf of Children and Families

On October 15, 2015, Beth Graham, Director at plaintiffs’ law firm Grant & Eisenhofer, will present updates on the Zofran (ondansetron) litigation. Grant & Eisenhofer has been at the forefront of the litigation, filing the first case and several others thereafter representing plaintiffs alleging that the anti-nausea drug manufactured by GlaxoSmithKline caused birth defects such as cleft palate and congenital heart defects. Ms. Graham will be discussing the status of the Zofran (ondansetron) litigation, including the science behind the drug’s effects.

If you or a loved one took Zofran (ondansetron) during your first trimester and your child was born with a congenital heart defect or cleft palate, call 877-978-0169 for a free, confidential legal consultation of your potential claim.

Real Time Analytics